Viewing Study NCT06311851


Ignite Creation Date: 2025-12-24 @ 11:40 PM
Ignite Modification Date: 2026-03-14 @ 7:20 PM
Study NCT ID: NCT06311851
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2024-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Transarterial Chemoembolization (TACE) Plus Bevacizumab for Liver Metastases
Sponsor: Pardis Noor Medical Imaging and Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
None Metastatic Cancer View
None Liver Metastases View
Keywords: